Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Pharmacokinetics, Safety, Tolerability and Immunogenicity of HZBio1 in Healthy Chinese Volunteers

NCT04765995 is registered in ClinicalTrials.gov with Hangzhou Grand Biologic Pharmaceutical, Inc. as lead sponsor.

NCT NCT04765995
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04765995 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Pharmacokinetics, Safety, Tolerability and Immunogenicity of HZBio1 in Healthy Chinese Volunteers
Lead sponsor
Hangzhou Grand Biologic Pharmaceutical, Inc.
Phase
Phase 1
Overall status
Completed
Start date
March 1, 2021
Completion date
January 14, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants